{"name":"Perfuse Therapeutics, Inc.","slug":"perfuse-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOQnBHYk9ZMWlBOF85bld5VnBlSktXcjA3NkdFa1RyOUlNZWZ0T001NXoxUTBtdEd0MFJ2aUZtZjl6dXd0aWgyV3BjUkFyUUxqVWpDUld1UlRjZDJ6Z3dfUFl4Z1NrWmtsT3pTMmxCY3lrallsWmFLZVF4a2g3QXpCR3R1Qkp1YXVkLXlLMy1JS0N0OTBRVzJ2Rkw2NjFuNDB1MGxaNlZPdnFnQ2dycTRhYg?oc=5","date":"2025-09-15","type":"pipeline","source":"Contract Pharma","summary":"FUJIFILM Biosciences Introduces BalanCD HEK293 Perfusion A Medium - Contract Pharma","headline":"FUJIFILM Biosciences Introduces BalanCD HEK293 Perfusion A Medium","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxOTlQzRkpQQlZDZXVlTFU3RzJWVV9HN3RhdWxyQ1gxdGJDaHFvZWpFQy1tOWRDbXhESDk2RkVWajdQZ2NhSTFncGlxTF9WTEVXMTdYZlhWdmd6NVI3b1FTbGdCZjNGTXBrVWp3S19GUF9DZlh0OFF3RXI0cU1XMFZhVXFzZjJZVkNpUU95bm9Jc0Y3Sm9yMkFoQ1dTTzNPb29PY0MwZ2VWaXJNR3d0WHgtY1BXV0FFWlMzZFRwdGl6VmR5U2xGMUNSLTRLdm9UQ2p6dVlvYU1BemYySTVLTE5va3ZFdmxvb0thRXNUNzlCVWJld0VuUDZn?oc=5","date":"2025-09-09","type":"pipeline","source":"PR Newswire","summary":"Open-Angle Glaucoma Market Outlook Brightens as Emerging Therapies Reshape Treatment Paradigms | DelveInsight - PR Newswire","headline":"Open-Angle Glaucoma Market Outlook Brightens as Emerging Therapies Reshape Treatment Paradigms | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxQeFByNHFRWmVoc3BXZDhzY3ZPWkpOdVVrLXlHTjR4NldPenpINGxFeFdnTWo5LW5pclpOdzBxOXFYeU1WOW8zQU9CbndCN2xIaVU3b0xzWE5lV2hjdkhRck52M1libVFTZmtwaEtMcmhCdTZWcmdyTUxDb1pMcHYtRWZpVjdUY2lTMnZ2SXpRLS12NkxvN3VVc2dkbi1na29qdE9WdkZpZW4xQW9fTHpqcVZsTURhS21wUFV3UU5xWEpBN3RmRzg2VnFWanJfNVY1dDB1VGxKblNYLVMtb0hWR1lnWkxpU2tV?oc=5","date":"2025-07-09","type":"trial","source":"Ophthalmology Times Europe","summary":"Perfuse Therapeutics shares findings from glaucoma and diabetic retinopathy trials of PER-001 - Ophthalmology Times Europe","headline":"Perfuse Therapeutics shares findings from glaucoma and diabetic retinopathy trials of PER-001","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQNWFZYjVvT0ctUnktQ2ZIdTJPem8wRUtERWo5Vm1YRmJJWC1FSTVhdHliNTBzVFQ5WmJhZzJsZ09uUURsUXNmNzFfZTZRWXVqT3dMTFVpdlVsNGhIUlhwVUlCTk5XeV95dklYNzRDNjRUdjlqTExBN3loaGVIaDk0QzdGOHltNm1HaWxDLUdMTVVJdmoySW5UZVhTbXJjYWpCMEY4?oc=5","date":"2025-06-26","type":"pipeline","source":"The Business Journals","summary":"Eye-focused biotech Perfuse Therapeutics zeroes in on pivotal studies to restore vision - The Business Journals","headline":"Eye-focused biotech Perfuse Therapeutics zeroes in on pivotal studies to restore vision","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxOeGRmSzFUTVh1QVUzVWt2MFpDODJ3OURBdEhfUmFrdmZQNjQ1bFc2cEh5UFlfcl9JNUZLRHZaaFcwTUctaV8tMUdoZTJISkx4VWRsbkM2N1JiYzJBRkNhUUdydzVSUFBscm1ac1lwNHdoWUtxOHRwUnQySVlYazlIVWJWYkNPZzhvMXhNbVJxUFRNMEpQRGNab2tBQmtfYUptSmJKU0JPc1hpR0s5Uld2MThaSEhMNGdacXlCRllVTmVxTlNYZVN0bkpXRUZiZ3FQX09IZW5zS0xBVDVkRVE2MGlGM3EtTmdmQjhwYWhKUXJkMk5CdGhlNWJCN2xQRzJoR2M5SWl2V2JkZw?oc=5","date":"2025-06-24","type":"trial","source":"PR Newswire","summary":"Perfuse Therapeutics Announces Positive Results from Phase 2 Clinical Trials in Glaucoma and Diabetic Retinopathy Patients - PR Newswire","headline":"Perfuse Therapeutics Announces Positive Results from Phase 2 Clinical Trials in Glaucoma and Diabetic Retinopathy Patien","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxNRUlVdWhac3I4SkZDMnBiYkpCcXhfaVJWdjYwOEMzTEhnVW8zeEhvS0h1R05Cb2RvNWlINUNWVUFCbHhvYVhLR3J1eXhfQmlyS2U2Ylh0SXpIb2Zfem14dXdST1dUdFFCWTgzcjFNWnJaM3FLN0xVUi1ITWd4cWpWellpX2s0MFBVMzRjVmh5MS1WRFB6V1dCa0FMdjdqbUt0SmJrVUVXa1JwcGVxLVBodlo1MGZ5UWU4RU9nR2xlTEhqN3hKVjBySUJiVERibE5ELUJuSHZtZWppaEdnSlkxVUpOUVgyZHVHUVF6VWt5NWxzaDBmMnVTOFpqVFVuVFpXQWV1bVJkakpFcVJ4UHZ6eUFrSHYtRTJ6QVd5Qi1kNmN4dGFOZ04zQjAteUdEQQ?oc=5","date":"2025-05-06","type":"trial","source":"PR Newswire","summary":"Perfuse Therapeutics Announces Positive Results from the Completed Phase 1/2a Clinical Trial of PER-001 Intravitreal Implant in Patients with Glaucoma - PR Newswire","headline":"Perfuse Therapeutics Announces Positive Results from the Completed Phase 1/2a Clinical Trial of PER-001 Intravitreal Imp","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxONHRLMUl6cHAwNHA5TlFCbndYTmpQWmp3bmpFWEpTN1lBLVQzVHZwU0JDckJ5XzhweDNzdF9XcFVEeDk4ZlQ1RjRLcjFSQzZ2MjJac0xZWjRLaTl0bzE3dzA2V29oVlhtaWgxRC1qS1d6eFZoMl92QW01UkdiRnVrSm5kYlRHeENqUnZpMWJxd1ZJNU9BenY0ZmpNUzlXcjA3SXhYTFVfOUNpMzd1c2x6ZnlMTmhhcVpJc1p0bjVfVQ?oc=5","date":"2025-04-25","type":"trial","source":"clinicalleader.com","summary":"The Future of Glaucoma Therapy: Adaptive Trial Design and Patient-Centric Protocols - clinicalleader.com","headline":"The Future of Glaucoma Therapy: Adaptive Trial Design and Patient-Centric Protocols","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxQbWFmM1Z3NGYwTllzRlBfa095OXROUERaQy1EWkkxc2FvYU1FMW1fVi1ZVXk0TndLWVBmeWRScE8tLTNMM1Awc2ZySHk4OG13VmNjeldjcXFMdkhfQ1luZGpnWU5mbUhYMmV1LW5VV2Uyd3RhcjMxYUxLMUNReGl6ZzlySTROaWZLdnQ2ZjRWZzRJMXVVZVpxSkRtNEdKbWtvaXBBTUJFWGl3RW5OVkNsYnYxZ0hRTFhwZWlaaVpzWWZJTW5oY1FlNjIxdWhBNk9faWF6U3JRd0xlZ21WcWNuRHZsRGhsMjgzYXlJUnRsbkJhVWI5Y3dfcGw2bEZLaXZhMXA1SDFCQmJxRGJxVVFhZWx3ZFpqY2Z6dW01cjUyWEtOZDJmYzAzeGVkUUY2UVQwcXZxR1pzdWZ5TlNDYW8xNVBraE4?oc=5","date":"2025-04-21","type":"pipeline","source":"PR Newswire","summary":"Perfuse Therapeutics Announces Oral Presentation on PER-001 Intravitreal Implant for Glaucoma at the Association for Research in Vision and Ophthalmology (ARVO) Meeting - PR Newswire","headline":"Perfuse Therapeutics Announces Oral Presentation on PER-001 Intravitreal Implant for Glaucoma at the Association for Res","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQeVZiWnk0SjJ4STZyRmlRQXB0M0ZDeFEzeXBRa3JfSFdpeU41bGNZWk03SExiZUFGTkZfZkZwUGZaQUZwOTJYOEhjOHFIbkJDenpObEhsOHA2S19hZUsyYkpLbUtwNlhyWXVKNTZ3QVd1MFVIM3ZRWlZteXBnOHJDak1nZjAwZ2l4bG5SeVExcVI0TFBLV2FTYVNtQkJ4Ym9FUkJGQy1iQVIzRE1rNWJTRUdsYXJWc3RaLUwwT0o4S1JSUWlCdTU2OHlOYnNKdlNjUkV3Rlg1TjQza2w5ZEZJ?oc=5","date":"2025-02-28","type":"deal","source":"BioPharma APAC","summary":"Sunflower Therapeutics and PharmNXT Biotech Partner to Launch Daisy Petal™ Perfusion Bioreactor in Asia - BioPharma APAC","headline":"Sunflower Therapeutics and PharmNXT Biotech Partner to Launch Daisy Petal™ Perfusion Bioreactor in Asia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxQeHhISHVyb2Z5d2h0aGoyZW4takJhLTlQaDlYbFFlaTRvMnBrN3h6cEttemhWelM0SzRkRFlzVlkzTkdET1dqb2xZcVdjZ0pKWGZIVnd0QnBDRHJjN0J3WXZmaWRpU0g4VndCYk9zSE94dF80VWNWX01MYXpJci02SFozdHlOdlR2TkM0ckNpdjBzVHE5U2hVUzc0U0dMODBXZkNYY08xOFh1OE53eWRRYi03cUIwQlh3d0JvTU41djhNMm9Mc3hBelZldmRETjlQd3ptNmlkY2RuQm9zR1F4WlMzeVQyUnhxeDdBSUNSbjRJX1NLVjI0ZEs0bmY3dWh4dDd1TFZKbjlpNTlIeXdqdm9PWG1mS3hEMTNTTmRjZw?oc=5","date":"2025-01-20","type":"trial","source":"GlobeNewswire","summary":"Advancements in Ocular Hypertension Clinical Trial Pipeline - GlobeNewswire","headline":"Advancements in Ocular Hypertension Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5hRnl3VmlvcXBQWk9kOFdCOHEzWWlWd2huU3lNNlZaMGkyampKb185R0lHV1hoT2x6cWZDaXprVkJDUFdhc2J2UkhUaWRYajN4LXVRWXQ0VEV0SE1UOTNF?oc=5","date":"2019-12-06","type":"pipeline","source":"nature.com","summary":"Improved Visualization of the Necrotic Zone after Microwave Ablation Using Computed Tomography Volume Perfusion in an In Vivo Porcine Model - nature.com","headline":"Improved Visualization of the Necrotic Zone after Microwave Ablation Using Computed Tomography Volume Perfusion in an In","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPbmZQc0hHVmtGdEFBMEpQUEtNUFZTV0dKN1d5VkFFekcyVm8tbEZvMTJxM3lydjR5WVc4UXQxbnZDdXVEb0R4TG5WeUhmUExwRUJULUpES3QyNkVIWkFTXzI1TVNLTmE1d3RIeE5CUkhXUElDUEdPYksxSngxZm9OMUNKTllDYWQ0N3FHOHdwaUwzQQ?oc=5","date":"2015-12-20","type":"regulatory","source":"dicardiology.com","summary":"FDA Reviews CorVue SPECT Pharmacologic Stress Agent - dicardiology.com","headline":"FDA Reviews CorVue SPECT Pharmacologic Stress Agent","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}